Your browser doesn't support javascript.
loading
An FGFR3/MYC positive feedback loop provides new opportunities for targeted therapies in bladder cancers.
Mahe, Mélanie; Dufour, Florent; Neyret-Kahn, Hélène; Moreno-Vega, Aura; Beraud, Claire; Shi, Mingjun; Hamaidi, Imene; Sanchez-Quiles, Virginia; Krucker, Clementine; Dorland-Galliot, Marion; Chapeaublanc, Elodie; Nicolle, Remy; Lang, Hervé; Pouponnot, Celio; Massfelder, Thierry; Radvanyi, François; Bernard-Pierrot, Isabelle.
Affiliation
  • Mahe M; Institut Curie, CNRS, UMR144, Equipe Labellisée Ligue contre le Cancer, PSL Research University, Paris, France.
  • Dufour F; CNRS, UMR144, Sorbonne Universités UPMC Université Paris 06, Paris, France.
  • Neyret-Kahn H; Institut Curie, CNRS, UMR144, Equipe Labellisée Ligue contre le Cancer, PSL Research University, Paris, France.
  • Moreno-Vega A; CNRS, UMR144, Sorbonne Universités UPMC Université Paris 06, Paris, France.
  • Beraud C; Institut Curie, CNRS, UMR144, Equipe Labellisée Ligue contre le Cancer, PSL Research University, Paris, France.
  • Shi M; CNRS, UMR144, Sorbonne Universités UPMC Université Paris 06, Paris, France.
  • Hamaidi I; Institut Curie, CNRS, UMR144, Equipe Labellisée Ligue contre le Cancer, PSL Research University, Paris, France.
  • Sanchez-Quiles V; CNRS, UMR144, Sorbonne Universités UPMC Université Paris 06, Paris, France.
  • Krucker C; UROLEAD SAS, School of Medicine, Strasbourg, France.
  • Dorland-Galliot M; Institut Curie, CNRS, UMR144, Equipe Labellisée Ligue contre le Cancer, PSL Research University, Paris, France.
  • Chapeaublanc E; CNRS, UMR144, Sorbonne Universités UPMC Université Paris 06, Paris, France.
  • Nicolle R; Department of Urology, Nouvel Hôpital Civil, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
  • Lang H; Institut Curie, CNRS, UMR144, Equipe Labellisée Ligue contre le Cancer, PSL Research University, Paris, France.
  • Pouponnot C; CNRS, UMR144, Sorbonne Universités UPMC Université Paris 06, Paris, France.
  • Massfelder T; Institut Curie, CNRS, UMR144, Equipe Labellisée Ligue contre le Cancer, PSL Research University, Paris, France.
  • Radvanyi F; CNRS, UMR144, Sorbonne Universités UPMC Université Paris 06, Paris, France.
  • Bernard-Pierrot I; Institut Curie, CNRS, UMR144, Equipe Labellisée Ligue contre le Cancer, PSL Research University, Paris, France.
EMBO Mol Med ; 10(4)2018 04.
Article in En | MEDLINE | ID: mdl-29463565
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Receptor, Fibroblast Growth Factor, Type 3 Type of study: Prognostic_studies Limits: Humans Language: En Journal: EMBO Mol Med Journal subject: BIOLOGIA MOLECULAR Year: 2018 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Receptor, Fibroblast Growth Factor, Type 3 Type of study: Prognostic_studies Limits: Humans Language: En Journal: EMBO Mol Med Journal subject: BIOLOGIA MOLECULAR Year: 2018 Document type: Article Affiliation country: Country of publication: